Chih-Chen Hong
Overview
Explore the profile of Chih-Chen Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chung K, Chen Y, Hong C, Chang I, Lin S, Liang L, et al.
Biochem Biophys Rep
. 2022 Jul;
31:101303.
PMID: 35800619
Hepatocellular carcinoma (HCC) is the main threat for the patients infected with hepatitis B virus (HBV), but the oncogenic mechanism of HBV-related HCC is still controversial. Previously, we have found...
2.
Lai H, Li C, Hong C, Sun H, Chiu C, Ou D, et al.
Mol Oncol
. 2019 Jan;
13(4):928-945.
PMID: 30657254
Hepatocellular carcinoma (HCC) is a lethal human malignancy and a leading cause of cancer-related death worldwide. Patients with HCC are often diagnosed at an advanced stage, and the prognosis is...
3.
Huang S, Chang I, Hong C, Yen T, Chen C, Wu C, et al.
Hepatol Commun
. 2018 Jun;
2(6):747-759.
PMID: 29881825
Metabolic risk factors, such as obesity, fatty liver, high lipidemia, and diabetes mellitus are associated with increased risk for nonviral hepatocellular carcinoma (HCC); however, few nonviral HCC studies have stratified...
4.
Chen H, Chang Y, Tseng C, Chiu C, Hong C, Wang W, et al.
Ann Surg Oncol
. 2017 Feb;
24(Suppl 3):685-686.
PMID: 28160139
No abstract available.
5.
Kuo T, Tan C, Chang Y, Hong C, Lee W, Chen M, et al.
J Clin Invest
. 2017 Jan;
127(1):402.
PMID: 28045406
No abstract available.
6.
Chang I, Huang S, Chen P, Chen C, Chen C, Wu C, et al.
Medicine (Baltimore)
. 2016 Apr;
95(15):e3284.
PMID: 27082566
Hepatocellular carcinoma (HCC) is the leading cancer death in Taiwan. Chronic viral hepatitis infections have long been considered as the most important risk factors for HCC in Taiwan. The previously...
7.
Chang Y, Chiu C, Lee K, Hong C, Wang Y, Cheng C, et al.
Am J Respir Crit Care Med
. 2015 Apr;
192(1):64-75.
PMID: 25906011
Rationale: CARD-recruited membrane-associated protein 3 (CARMA3) is a novel scaffold protein that regulates nuclear factor (NF)-κB activation; however, the underlying mechanism of CARMA3 in lung cancer stemness and metastasis remains...
8.
Chang Y, Chen H, Tseng C, Hong C, Ma J, Hung M, et al.
Oncotarget
. 2014 Oct;
5(21):10558-70.
PMID: 25301734
Elevated expression of heat shock protein 5 (HSPA5) promotes drug resistance and metastasis and is a marker of poor prognosis in breast cancer patients. Adenovirus type 5 E1A gene therapy...
9.
Chen H, Chang Y, Tseng C, Chiu C, Hong C, Wang W, et al.
Ann Surg Oncol
. 2014 Sep;
22(3):889-98.
PMID: 25212833
Background: Triple-negative breast cancer (TNBC) is defined by reduced expression of the estrogen receptor, progesterone receptor, and HER2. TNBC is an especially aggressive group of breast cancers with poor prognosis....
10.
Su C, Su Y, Chiu C, Chang Y, Hong C, Yu Y, et al.
Ann Surg Oncol
. 2014 Sep;
21 Suppl 4:S767-75.
PMID: 25212831
Background: Vascular endothelial growth factor-C (VEGF-C) plays an important role during cancer progression and metastasis through activation of VEGF receptors. However, the role of VEGF-C in esophageal squamous cell carcinoma...